ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-6.59%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(+38%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
15.74%
Top 10 Holdings %
Top 10 Hldgs %
53.82%
Holding
52
New
30
Increased
–
Reduced
7
Closed
13
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$12.7M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$8.99M |
| 3 |
Sanofi
SNY
|
$8.75M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$8.35M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$7.69M |
Top Sells
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$16.1M |
| 2 |
Cogent Biosciences
COGT
|
$9.75M |
| 3 |
argenx
ARGX
|
$9.58M |
| 4 |
Lantheus
LNTH
|
$7.59M |
| 5 |
Guardant Health
GH
|
$6.45M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.7M | 8.36% | +92,506 | New | +$12.7M |
|
|
2
Ultragenyx Pharmaceutical
RARE
$2.89B
| $8.99M | 5.93% | +217,075 | New | +$8.99M |
|
|
3
Sanofi
SNY
$121B
| $8.75M | 5.77% | +230,000 | New | +$8.75M |
|
|
4
Karyopharm Therapeutics
KPTI
$61.7M
| $8.35M | 5.51% | +1,528,580 | New | +$8.35M |
|
|
5
Ironwood Pharmaceuticals
IRWD
$214M
| $7.69M | 5.08% | +742,570 | New | +$7.69M |
|
6
Rocket Pharmaceuticals
RCKT
$354M
| $7.65M | 5.05% | +479,506 | New | +$7.65M |
|
7
GSK
GSK
$79.9B
| $7.51M | 4.95% | +255,000 | New | +$7.51M |
|
|
AMRN
8
Amarin Corp
AMRN
$311M
| $6.93M | 4.58% | +6,358,288 | New | +$6.93M |
|
9
Alkermes
ALKS
$4.78B
| $6.7M | 4.42% | +300,000 | New | +$6.7M |
|
10
Mersana Therapeutics
MRSN
$36.5M
| $6.3M | 4.16% | +931,539 | New | +$6.3M |
|
|
SYRS
11
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.59M | 3.69% | 868,403 -2,496,492 | -74% | -$16.1M |
|
|
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.6M | 3.03% | +74,262 | New | +$4.6M |
|
|
MDVL
13
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $4.57M | 3.02% | 5,894,897 | – | – |
|
14
Gossamer Bio
GOSS
$562M
| $4.52M | 2.98% | 377,000 -323,000 | -46% | -$3.87M |
|
15
Sana Biotechnology
SANA
$777M
| $4.41M | 2.91% | +735,250 | New | +$4.41M |
|
|
16
argenx
ARGX
$43.6B
| $4.32M | 2.85% | 12,240 -27,130 | -69% | -$9.58M |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $4.32M | 2.85% | +110,222 | New | +$4.32M |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $3.66M | 2.42% | +598,172 | New | +$3.66M |
|
19
Adicet Bio
ACET
$59.9M
| $3.48M | 2.29% | +244,400 | New | +$3.48M |
|
20
Galapagos
GLPG
$2.07B
| $3.26M | 2.15% | +76,489 | New | +$3.26M |
|
21
Repligen
RGEN
$6.88B
| $3.13M | 2.07% | +16,724 | New | +$3.13M |
|
|
22
Cogent Biosciences
COGT
$1.69B
| $3.04M | 2.01% | 204,014 -653,338 | -76% | -$9.75M |
|
|
ISO
23
DELISTED
IsoPlexis Corporation Common Stock
ISO
| $2.62M | 1.73% | 1,522,364 -127,754 | -8% | -$220K |
|
24
Rapid Micro Biosystems
RPID
$107M
| $2.26M | 1.49% | 699,664 | – | – |
|
25
Atea Pharmaceuticals
AVIR
$267M
| $2.05M | 1.35% | +360,000 | New | +$2.05M |
|